JPS58198466A - ５−チアプロスタグランジン類およびその製造法 - Google Patents

５−チアプロスタグランジン類およびその製造法

Info

Publication number
JPS58198466A
JPS58198466A JP57078172A JP7817282A JPS58198466A JP S58198466 A JPS58198466 A JP S58198466A JP 57078172 A JP57078172 A JP 57078172A JP 7817282 A JP7817282 A JP 7817282A JP S58198466 A JPS58198466 A JP S58198466A
Authority
JP
Japan
Prior art keywords
group
formula
hydrogen atom
thiaprostaglandins
following formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57078172A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0141142B2 (enrdf_load_stackoverflow
Inventor
Atsuo Hasato
篤夫 羽里
Toshio Tanaka
利男 田中
Seiji Kurozumi
精二 黒住
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP57078172A priority Critical patent/JPS58198466A/ja
Publication of JPS58198466A publication Critical patent/JPS58198466A/ja
Publication of JPH0141142B2 publication Critical patent/JPH0141142B2/ja
Granted legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP57078172A 1982-05-12 1982-05-12 ５−チアプロスタグランジン類およびその製造法 Granted JPS58198466A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57078172A JPS58198466A (ja) 1982-05-12 1982-05-12 ５−チアプロスタグランジン類およびその製造法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57078172A JPS58198466A (ja) 1982-05-12 1982-05-12 ５−チアプロスタグランジン類およびその製造法

Publications (2)

Publication Number Publication Date
JPS58198466A true JPS58198466A (ja) 1983-11-18
JPH0141142B2 JPH0141142B2 (enrdf_load_stackoverflow) 1989-09-04

Family

ID=13654523

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57078172A Granted JPS58198466A (ja) 1982-05-12 1982-05-12 ５−チアプロスタグランジン類およびその製造法

Country Status (1)

Country Link
JP (1) JPS58198466A (enrdf_load_stackoverflow)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59112962A (ja) * 1982-12-20 1984-06-29 Teijin Ltd ５―チア―δ↑７―プロスタグランジンａ類およびその製造法
JPS61233664A (ja) * 1985-04-10 1986-10-17 Teijin Ltd ５−チアプロスタグランジンｅ↓１類およびその製造法
WO1994019319A1 (en) * 1993-02-19 1994-09-01 Taisho Pharmaceutical Co., Ltd. Process for producing intermediate for 13,14-didehydroprostaglandin e
US6462081B1 (en) 1998-07-15 2002-10-08 Ono Pharmaceutical Co., Ltd. 5-thia-ω-substituted phenyl-prostaglandin E derivatives, process for producing the same and drugs containing the same as the active ingredient
EP1243278A3 (en) * 1992-02-07 2003-02-26 Vasogen, Inc. Method of increasing the concentration of nitric oxide in blood
US6569467B1 (en) 1992-02-07 2003-05-27 Vasogen Ireland Limited Treatment of autoimmune diseases
US6669965B2 (en) 1992-02-07 2003-12-30 Vasogen Ireland Limited Method of treating atherosclerosis

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0653389A (ja) * 1992-08-03 1994-02-25 Nec Corp 半導体パッケージ

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59112962A (ja) * 1982-12-20 1984-06-29 Teijin Ltd ５―チア―δ↑７―プロスタグランジンａ類およびその製造法
JPS61233664A (ja) * 1985-04-10 1986-10-17 Teijin Ltd ５−チアプロスタグランジンｅ↓１類およびその製造法
EP1243278A3 (en) * 1992-02-07 2003-02-26 Vasogen, Inc. Method of increasing the concentration of nitric oxide in blood
US6569467B1 (en) 1992-02-07 2003-05-27 Vasogen Ireland Limited Treatment of autoimmune diseases
US6669965B2 (en) 1992-02-07 2003-12-30 Vasogen Ireland Limited Method of treating atherosclerosis
WO1994019319A1 (en) * 1993-02-19 1994-09-01 Taisho Pharmaceutical Co., Ltd. Process for producing intermediate for 13,14-didehydroprostaglandin e
US5597938A (en) * 1993-02-19 1997-01-28 Taisho Pharmaceutical Co., Ltd. Process for producing intermediate for 13,14-didehydroprostaglandin E
US6462081B1 (en) 1998-07-15 2002-10-08 Ono Pharmaceutical Co., Ltd. 5-thia-ω-substituted phenyl-prostaglandin E derivatives, process for producing the same and drugs containing the same as the active ingredient

Also Published As

Publication number Publication date
JPH0141142B2 (enrdf_load_stackoverflow) 1989-09-04

Similar Documents

Publication Publication Date Title
HU181840B (en) Process for preparing 15-deoxy-16-hydroxy-16-substituted prostanoic acids
JPS58198466A (ja) ５−チアプロスタグランジン類およびその製造法
WO1986002923A1 (en) Process for preparing bicyclo ad3.3.0 bdoctenes
EP0591532A1 (en) Prostaglandin e 1? analogue
CH619691A5 (enrdf_load_stackoverflow)
US4294849A (en) Prostaglandin analogues
US4154950A (en) 15-Epi-15-methyl-16-phenoxy-PGE compounds
CA1060889A (en) 2a,2b-dihomo-15-alkylprostaglandin analogs
US4029693A (en) 2A,2B-Dihomo-11-deoxy-17(substituted phenyl)-18,19,20-trinor-PGE2 compounds and their corresponding esters
US4197407A (en) Prostenoic acids and esters
US3836581A (en) 1-alkoximino-2-(omega-substituted-alkyl)-2-cyclopentenes
US4130721A (en) 11-Deoxy PGE2 compounds
JPS596872B2 (ja) プロスタグランジンケイカゴウブツ ノ セイゾウホウホウ
US2853497A (en) 6, 8-bis (hydrocarbon substituted mercapto) 5-hydroxycaprylic acids and delta-lactones thereof
JPS6097926A (ja) 新規な４−ヒドロキシ−２−シクロペンテノン類およびその製造方法
JPH0115511B2 (enrdf_load_stackoverflow)
US4603208A (en) Certain polyprenyl intermediates
US3835180A (en) 15 alkoxy pge compounds
JPH06239779A (ja) 光学活性シクロペンテンジオールの製造方法
GB2129001A (en) Epoxycarbacyclin derivatives their preparation and use
US3923864A (en) 3-Oxa prostaglandin A-type compounds
US4245121A (en) Prostenoic acids and esters
US3920723A (en) 4-oxaprostaglandin e-type compounds
JPS6366176A (ja) ヒドロキノン誘導体の製造方法
CA1098124A (en) Process for the preparation of prostaglandin analogues